Physician profile
Michael Mccartney
NPI 1164541637
$3,472.37
in general payments reported to CMS, 2019-2025
45 companies · $862 in 2025
The $862 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.40 · 2020: $434 · 2021: $393 · 2022: $356 · 2023: $672 · 2024: $665 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $388.37 | 2020-2025 | |
| Novo Nordisk INC | $385.84 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $378.55 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $217.24 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $190.02 | 2020-2025 | |
| Glaxosmithkline, LLC. | $181.70 | 2020-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $171.48 | 2020-2025 | Otezla, Repatha, Repatha |
| Djo, LLC | $126.36 | 2024 | Chattanooga, Procare |
| Astellas Pharma US INC | $103.55 | 2020-2023 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $97.94 | 2020-2025 | Verquvo, Capvaxive, Vaxneuvance |
| Exact Sciences Corporation | $85.04 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boston Scientific Corporation | $84.29 | 2022-2025 | Ams 700 |
| Janssen Pharmaceuticals, INC | $66.75 | 2020-2024 | Xarelto |
| Amarin Pharma, INC. | $50.10 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.40 | 2020-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mccartney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.